Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Urologic Neoplasms × Ado-Trastuzumab Emtansine × Thoracic × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 5 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Lung Neoplasms 1 Genomic Instability 1 Gastrointestinal Neoplasms 1 Breast Neoplasms 1

Interventions

niraparib 1 atezolizumab 1 Etoposide 1 Diet 1 Cyclophosphamide 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02675829 2026-03-04

Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting

GenitourinaryThoracic

Urinary Bladder Neoplasms, Lung Neoplasms, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡